Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| acinar cell | 3 studies | 85% ± 11% |
Insufficient scRNA-seq data for expression of CTRC at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| pancreas | 100% | 466369.06 | 328 / 328 | 63% | 594.52 | 112 / 178 |
| spleen | 100% | 100.00 | 241 / 241 | 0% | 0 | 0 / 0 |
| prostate | 96% | 79.56 | 236 / 245 | 0% | 0.00 | 1 / 502 |
| lung | 91% | 52.68 | 524 / 578 | 1% | 0.02 | 9 / 1155 |
| peripheral blood | 91% | 80.57 | 841 / 929 | 0% | 0 | 0 / 0 |
| uterus | 86% | 48.72 | 147 / 170 | 2% | 0.05 | 11 / 459 |
| thymus | 81% | 57.76 | 531 / 653 | 7% | 0.21 | 43 / 605 |
| stomach | 83% | 86.40 | 297 / 359 | 3% | 0.31 | 9 / 286 |
| adrenal gland | 83% | 48.95 | 213 / 258 | 1% | 0.02 | 3 / 230 |
| adipose | 83% | 203.52 | 1004 / 1204 | 0% | 0 | 0 / 0 |
| breast | 82% | 117.98 | 378 / 459 | 0% | 0.01 | 3 / 1118 |
| kidney | 82% | 46.91 | 73 / 89 | 0% | 0.02 | 3 / 901 |
| bladder | 81% | 28.71 | 17 / 21 | 1% | 0.04 | 7 / 504 |
| ovary | 81% | 64.44 | 145 / 180 | 1% | 3.77 | 6 / 430 |
| intestine | 78% | 53.20 | 752 / 966 | 3% | 13.66 | 14 / 527 |
| esophagus | 76% | 69.70 | 1092 / 1445 | 2% | 0.03 | 3 / 183 |
| liver | 76% | 63.43 | 171 / 226 | 0% | 0.10 | 2 / 406 |
| skin | 76% | 62.71 | 1374 / 1809 | 0% | 0 | 0 / 472 |
| brain | 64% | 32.25 | 1680 / 2642 | 2% | 0.04 | 16 / 705 |
| blood vessel | 64% | 93.16 | 849 / 1335 | 0% | 0 | 0 / 0 |
| heart | 49% | 40.97 | 423 / 861 | 0% | 0 | 0 / 0 |
| muscle | 38% | 22.29 | 308 / 803 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 4% | 0.07 | 2 / 45 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0006874 | Biological process | intracellular calcium ion homeostasis |
| GO_0006508 | Biological process | proteolysis |
| GO_0008233 | Molecular function | peptidase activity |
| GO_0005515 | Molecular function | protein binding |
| GO_0004252 | Molecular function | serine-type endopeptidase activity |
| Gene name | CTRC |
| Protein name | Chymotrypsin-C (EC 3.4.21.2) (Caldecrin) Chymotrypsin C |
| Synonyms | DKFZp779K0837 CLCR |
| Description | FUNCTION: Regulates activation and degradation of trypsinogens and procarboxypeptidases by targeting specific cleavage sites within their zymogen precursors. Has chymotrypsin-type protease activity and hypocalcemic activity. . |
| Accessions | ENST00000375949.5 ENST00000375943.6 Q68DR9 Q99895 |